Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 425.63M | 967.84M | 982.29M | 999.78M | 1.02B |
| Total Depreciation and Amortization | 4.82M | 4.48M | 3.62M | 3.41M | 3.19M |
| Total Amortization of Deferred Charges | 3.49M | 3.18M | 3.18M | 2.36M | 2.36M |
| Total Other Non-Cash Items | -169.35M | -96.54M | -93.88M | 89.74M | 68.50M |
| Change in Net Operating Assets | -538.70M | 79.76M | 98.08M | 34.73M | 58.13M |
| Cash from Operations | -274.11M | 958.71M | 993.28M | 1.13B | 1.16B |
| Capital Expenditure | -6.79M | -5.83M | -5.11M | -2.65M | -2.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -168.88M | -444.12M | -348.39M | -267.32M | -1.03B |
| Cash from Investing | -175.67M | -449.95M | -353.50M | -269.97M | -1.03B |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -28.40M | -25.40M | -20.40M | -19.00M | -17.77M |
| Issuance of Common Stock | 30.52M | 46.52M | 48.52M | 31.98M | 35.19M |
| Repurchase of Common Stock | -512.76M | -406.76M | -406.76M | -406.76M | -602.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00K | -2.46M |
| Cash from Financing | -79.55M | -59.01M | -57.90M | -60.22M | -88.07M |
| Foreign Exchange rate Adjustments | 27.97M | 3.35M | -7.73M | -8.68M | -25.60M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -501.36M | 453.09M | 574.16M | 791.16M | 11.22M |